Empirical Wealth Management’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$447K Buy
+279,259
New +$531K 0.01% 817

Other funds holding ALLO

Empirical Wealth Management's ALLO Position: Q3 2026 in Review

Empirical Wealth Management opened a new position in Allogene Therapeutics (ALLO) in Q3 2026: 279,259 shares worth $447K. The stake represents 0.01% of the portfolio and ranks #817 among its holdings.

198 funds tracked by Wall St. Rank hold ALLO as of Q3 2026.

  • Empirical Wealth Management held 279,259 shares of Allogene Therapeutics worth $447K as of Q3 2026.
  • Allogene Therapeutics was a new Empirical Wealth Management position in Q3 2026.
  • Allogene Therapeutics made up 0.01% of Empirical Wealth Management's portfolio in Q3 2026, its #817 holding.
  • 198 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q3 2026.

Based on Empirical Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.